India, Netherlands to jointly research stroke, dementia causes

Image
IANS New Delhi
Last Updated : Jan 30 2014 | 9:52 PM IST

India and the Netherlands Thursday launched a joint research project to go into the causes of stroke and dementia.

Visiting Dutch Health, Welfare and Sports Minister Edith Schippers, and India's Science and Technology Minister Jaipal Reddy launched the research project to be jointly executed by the All India Institute for Medical Sciences (AIIMS) here and Erasmus Medical Center, Rotterdam (the Netherlands).

The two top medical research institutes will research into the causes of stroke and dementia.

India's department of biotechnology, under the science and technology ministry, has committed around Rs.33 crore towards the project, said a Netherlands embassy press release.

The study consists of a large-scale, long term study following thousands of people. The launching ceremony took place in AIIMS here.

Stroke mortality in India is 25 times that of malaria and research has shown that Indians may be more susceptible to stroke than their western counterparts.

The joint Indo-Dutch study will investigate into this intriguing finding. Beginning in 2015, a group of 15,000 people aged 50 and above from Delhi and Gurgaon area will be followed for 10 years to assess risk factors associated with stroke and Alzheimer's disease.

The findings will be compared with those of similar studies being carried out by Erasmus MC in the area around Rotterdam.

Although epidemics still do occur in India year after year, the majority of the disease burden is now caused by non-communicable diseases (NCDs) such as diabetes and stroke.

These diseases largely affect the middle-aged and older populations.

As India's population is ageing rapidly, the number of Indians suffering from NCDs will see a tremendous increase as well. With a view of improving the quality of life of its older people the Indian government is stepping up its research into aging and associated diseases.

Other collaborations between AIIMS and the Erasmus MC in the areas of neuroscience and gastroenterology are also ongoing, the statement said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 30 2014 | 9:48 PM IST

Next Story